Huada Yixue

investment firm

About

Huada Yixue is a department of Medical Laboratory Science, Clinical Immunology, Serology.

  • Beijing,Beijing,China

Details

Industries
Clinical Trials,Genetics,Medical
Founded date
Jan 20, 2014
Operating Status
Active
Also Known As
华大医学,北京华大医学检验所有限公司

Investments

Number of Investments
Number of Lead Investments
2
1
Huada Yixue has made 2 investments. Their most recent investment was on Jan 29, 2018, when WeGene raised ¥20M.
Date Company Name
Round Money Raised Industry Lead Investor
Jan 29, 2018 WeGene
Series B ¥20M Biotechnology
Series A ¥10M Biotechnology Yes

Exits

Huada Yixue has had 1 exits. Huada Yixue most notable exits include Synbio Technologies

Date Company Name Exit Type Industry
Oct 9, 2017 Synbio Technologies IPO Biotechnology Detail

Acquisition

Huada Yixue has acquired 1 organizations. Their most recent acquisition was Qinglan Biotech on Jul 20, 2018. They acquired Qinglan Biotech for ¥50M.

Date Company Name
Industry Acquisition Type Price
Jul 20, 2018 Qinglan Biotech
Biotechnology acquisition ¥ 50M Detail